James W. Mitchell to Antidepressive Agents
This is a "connection" page, showing publications James W. Mitchell has written about Antidepressive Agents.
Connection Strength
1.422
-
Biological therapies for eating disorders. Int J Eat Disord. 2013 Jul; 46(5):470-7.
Score: 0.440
-
Psychosocial and pharmacological treatment of eating disorders: a review of research findings. J Clin Psychol. 1999 Jun; 55(6):685-97.
Score: 0.166
-
Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS-2) study. Obesity (Silver Spring). 2014 Aug; 22(8):1799-806.
Score: 0.116
-
A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eat Disord. 1993 Nov; 14(3):229-47.
Score: 0.113
-
A comparison of duloxetine plasma levels in postbariatric surgery patients versus matched nonsurgical control subjects. J Clin Psychopharmacol. 2013 Aug; 33(4):479-84.
Score: 0.111
-
Possible risk factors for increased suicide following bariatric surgery. Obesity (Silver Spring). 2013 Apr; 21(4):665-72.
Score: 0.108
-
Antidepressants vs. psychotherapy in the treatment of bulimia nervosa. Psychopharmacol Bull. 1993; 29(1):115-9.
Score: 0.106
-
Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort. Surg Obes Relat Dis. 2012 Jan-Feb; 8(1):62-6.
Score: 0.092
-
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa. J Clin Psychopharmacol. 1989 Aug; 9(4):291-3.
Score: 0.084
-
Towards the pharmacotherapy of eating disorders. Expert Opin Pharmacother. 2003 Oct; 4(10):1659-78.
Score: 0.056
-
Rational therapy of eating disorders. Drugs. 1994 Sep; 48(3):372-9.
Score: 0.030